FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of the general formula
or its pharmaceutically acceptable salt. In formula I, R1 is a hydrogen atom; R2 is a hydrogen atom and X is an unbranched C1-6 alkylene group. The invention also relates to a pharmaceutical composition comprising a compound of formula I, for use in photodynamic therapy or diagnostic method.
EFFECT: increased efficiency.
20 cl, 2 dwg, 3 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID AND ITS DERIVATIVES | 2005 |
|
RU2392266C2 |
| 5-AMINOLEVULINIC ACID ESTERS AS PHOTOSENSITIVE AGENTS IN PHOTOCHEMOTHERAPY | 2001 |
|
RU2246483C2 |
| HISTONES DEACETYLASES (HDACS) INHIBITORS | 2013 |
|
RU2629947C2 |
| SELECTIVE LIGANDS OF G-QUADRUPLEX STRUCTURES OF NUCLEIC ACIDS | 2015 |
|
RU2588131C1 |
| 2,3,5-TRISUBSTITUTED PYRROLS, BASED PHARMACEUTICAL COMPOSITION AND DRUG, METHOD FOR PREPARING COMPOUNDS (VERSIONS) | 2010 |
|
RU2549885C2 |
| AROMATASE INHIBITORS | 2010 |
|
RU2572244C2 |
| SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
| SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
| LIGANDS FOR AGGREGATED MOLECULES OF TAU-PROTEIN | 2009 |
|
RU2518892C2 |
| ALKYNYLPYRIDINE INHIBITOR OF PROLYL HYDROXYLASE, A METHOD FOR PRODUCTION THEREOF AND MEDICAL APPLICATION | 2015 |
|
RU2692494C1 |
